Offer - Urjas Oil for just ₹ 1 X
Calaptin 40 Tablet (30), a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of High BP, Angina. Secondary and off-label uses of Calaptin 40 Tablet (30) have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Calaptin 40 Tablet (30). Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Calaptin 40 Tablet (30) side effects, there are can be others also. These have been listed below. Usually, these side effects of Calaptin 40 Tablet (30) go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Calaptin 40 Tablet (30) is Severe for pregnant women and Mild for women who are breastfeeding. Further, the section on Calaptin 40 Tablet (30) related warnings talks about Calaptin 40 Tablet (30)'s effects on the liver, heart and kidney.
Calaptin 40 Tablet (30) is contraindicated in people with pre-existing medical conditions like Bradycardia (Slow Heart Rate), Heart Failure, Aortic Stenosis as it can result in adverse effects. Other conditions have been mentioned below in the Calaptin 40 Tablet (30) contraindications section.
Drug reaction of Calaptin 40 Tablet (30) with other medicines has been reported. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Calaptin 40 Tablet (30) is not safe while driving, and is is not addictive in nature.
Calaptin 40 Tablet (30) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Calaptin 40 Tablet (30) safe for pregnant women?
Calaptin shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Calaptin 40 Tablet (30) safe during breastfeeding?
Breastfeeding women can take Calaptin as it bears very minor side effects for them.
What is the effect of Calaptin 40 Tablet (30) on the Kidneys?
Very few cases of side effects of Calaptin on kidney have been reported.
What is the effect of Calaptin 40 Tablet (30) on the Liver?
Calaptin is rarely harmful for the liver.
What is the effect of Calaptin 40 Tablet (30) on the Heart?
Very few cases of side effects of Calaptin on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Calaptin 40 Tablet (30) unless your doctor advises you to do so -
Is this Calaptin 40 Tablet (30) habit forming or addictive?
Calaptin 40 Tablet (30) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Calaptin 40 Tablet (30), you should not drive or work on any heavy machine, as Calaptin 40 Tablet (30) can make you drowsy.
Is it safe?
Calaptin 40 Tablet (30) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Calaptin 40 Tablet (30) cannot treat any kind of mental disorder.
Interaction between Food and Calaptin 40 Tablet (30)
Eating certain foods may increase the time it takes Calaptin 40 Tablet (30) to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Calaptin 40 Tablet (30)
Consumption of alcohol and Calaptin 40 Tablet (30) together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Verapamil hydrochloride
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 535
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1263-1264